AU2006280230B2 - Use of peptides that bind to TPO receptor - Google Patents

Use of peptides that bind to TPO receptor Download PDF

Info

Publication number
AU2006280230B2
AU2006280230B2 AU2006280230A AU2006280230A AU2006280230B2 AU 2006280230 B2 AU2006280230 B2 AU 2006280230B2 AU 2006280230 A AU2006280230 A AU 2006280230A AU 2006280230 A AU2006280230 A AU 2006280230A AU 2006280230 B2 AU2006280230 B2 AU 2006280230B2
Authority
AU
Australia
Prior art keywords
peptide
peptide compound
nal
tpo
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2006280230A
Other languages
English (en)
Other versions
AU2006280230A1 (en
Inventor
Brian R. Macdonald
Jeffery Kenneth Weis
Edward John Yurkow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37734435&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2006280230(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Publication of AU2006280230A1 publication Critical patent/AU2006280230A1/en
Application granted granted Critical
Publication of AU2006280230B2 publication Critical patent/AU2006280230B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
AU2006280230A 2005-08-09 2006-08-03 Use of peptides that bind to TPO receptor Ceased AU2006280230B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/200,416 2005-08-09
US11/200,416 US7723295B2 (en) 2003-08-28 2005-08-09 Peptides and compounds that bind to a receptor
PCT/US2006/030359 WO2007021572A2 (en) 2005-08-09 2006-08-03 Use of peptides that bind to tpo receptor

Publications (2)

Publication Number Publication Date
AU2006280230A1 AU2006280230A1 (en) 2007-02-22
AU2006280230B2 true AU2006280230B2 (en) 2012-11-08

Family

ID=37734435

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006280230A Ceased AU2006280230B2 (en) 2005-08-09 2006-08-03 Use of peptides that bind to TPO receptor

Country Status (34)

Country Link
US (1) US7723295B2 (https=)
EP (1) EP1957517B1 (https=)
JP (1) JP2009504650A (https=)
KR (1) KR20080048026A (https=)
CN (1) CN101287749A (https=)
AR (1) AR055114A1 (https=)
AU (1) AU2006280230B2 (https=)
BR (1) BRPI0614647A2 (https=)
CA (1) CA2618958A1 (https=)
CR (1) CR9798A (https=)
CY (1) CY1114032T1 (https=)
DK (1) DK1957517T3 (https=)
EA (1) EA200800535A1 (https=)
EC (1) ECSP088169A (https=)
ES (1) ES2419005T3 (https=)
GT (1) GT200600361A (https=)
HR (1) HRP20130518T1 (https=)
IL (1) IL189361A (https=)
JO (1) JO2859B1 (https=)
MY (1) MY152177A (https=)
NI (1) NI200800040A (https=)
NO (1) NO344405B1 (https=)
NZ (1) NZ565497A (https=)
PE (1) PE20070416A1 (https=)
PL (1) PL1957517T3 (https=)
PT (1) PT1957517E (https=)
RS (1) RS52802B (https=)
SI (1) SI1957517T1 (https=)
SV (1) SV2008002648A (https=)
TW (1) TWI400081B (https=)
UA (1) UA96418C2 (https=)
UY (1) UY29736A1 (https=)
WO (1) WO2007021572A2 (https=)
ZA (1) ZA200802184B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091311B2 (en) * 1996-06-07 2006-08-15 Smithkline Beecham Corporation Peptides and compounds that bind to a receptor
KR20050093759A (ko) 2002-09-18 2005-09-23 오르토-맥네일 파마슈티칼, 인코퍼레이티드 혈소판 및 조혈 줄기세포의 생산을 증가시키는 방법
US20040149235A1 (en) * 2002-10-04 2004-08-05 Pogue Albert S. Apparatus and method for removal of waste from animal production facilities
US7615533B2 (en) * 2004-08-16 2009-11-10 Janssen Pharmaceutica N.V. TPO peptide compounds for treatment of anemia
US20090053242A1 (en) * 2006-01-25 2009-02-26 Amgen Inc. Thrombopoietic compounds
KR20110015448A (ko) * 2008-06-03 2011-02-15 얀센 파마슈티카 엔.브이. 암 치료와 관련된 혈액 질환을 예방하기 위한 ｔｐｏ 모방 펩티드
EP2725053B1 (en) 2011-06-23 2016-02-10 Shimadzu Corporation Branched amphipathic block polymer and molecular aggregate and drug delivery system using same
CA3070442A1 (en) 2017-07-26 2019-01-31 Janssen Pharmaceutica Nv Methods of protecting vascular integrity induced by targeted radiation therapy
MX2021008928A (es) 2019-01-25 2021-11-04 Janssen Pharmaceutica Nv Métodos para mejorar la protección contra lesiones vasculares y de organos, la recuperación hematopoyética y la supervivencia en respuesta a la radiacion corporal total/exposicion química.
CN113905754B (zh) 2019-01-25 2025-03-11 詹森药业有限公司 减轻起疱剂和腐蚀性气体毒性作用的方法
CN113766926A (zh) 2019-01-25 2021-12-07 詹森药业有限公司 与放射和/或放射模拟物治疗结合的减轻肝损伤和促进肝肥大、再生和细胞植入的方法
US20240156973A1 (en) * 2021-02-24 2024-05-16 Purdue Research Foundation Osteotropic compositions and uses thereof
WO2023056444A1 (en) 2021-10-01 2023-04-06 Janssen Pharmaceutica N.V. Methods of increasing progenitor cell production
WO2024095178A1 (en) 2022-11-01 2024-05-10 Janssen Pharmaceutica Nv Thrombopoietin mimetic for use in the treatment of acute liver failure

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005023834A2 (en) * 2003-08-28 2005-03-17 Ortho-Mcneil Pharmaceutical, Inc. Peptides and compounds that bind to thrombopoietin receptors

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5326558A (en) * 1989-08-08 1994-07-05 Genetics Institute, Inc. Megakaryocytopoietic factor
IL96477A0 (en) 1989-12-01 1991-08-16 Amgen Inc Megakaryocyte production
DK167813B1 (da) * 1989-12-07 1993-12-20 Carlbiotech Ltd As Pentapeptidderivat, farmaceutisk acceptable salte heraf, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende et saadant derivat
US5571508A (en) 1989-12-18 1996-11-05 Amrad Corporation Limited Method for the treatment of thrombocytopenia and pharmaceutical compositions useful therefor
IT1241395B (it) 1990-04-02 1994-01-10 Eniricerche Spa Composti immunogenici,il procedimento per la loro sintesi e loro impiego per la preparazione di vaccini antimalaria
US5141851A (en) * 1990-04-18 1992-08-25 Board Of Regents, The University Of Texas System Isolated farnesyl protein transferase enzyme
US5250732A (en) * 1991-07-18 1993-10-05 Genentech, Inc. Ketamine analogues for treatment of thrombocytopenia
US5270170A (en) * 1991-10-16 1993-12-14 Affymax Technologies N.V. Peptide library and screening method
ES2181691T5 (es) 1992-06-11 2007-10-01 Alkermes Controlled Therapeutics, Inc. Sistema de distribucion de proteina eritropoyetina.
JP3401005B2 (ja) * 1992-12-11 2003-04-28 ユニバーシティ オブ フロリダ 有害生物の防除のための材料および方法
AU8124694A (en) 1993-10-29 1995-05-22 Affymax Technologies N.V. In vitro peptide and antibody display libraries
SG47030A1 (en) 1994-01-03 1998-03-20 Genentech Inc Thrombopoietin
SK100896A3 (en) 1994-02-14 1997-10-08 Zymogenetics Inc Hematopoietic protein and materials and methods for making it
EP0668352A1 (en) 1994-02-14 1995-08-23 Kirin Brewery Company, Ltd. Protein having TPO activity
WO1995021626A1 (en) 1994-02-14 1995-08-17 University Of Washington Methods for stimulating erythropoiesis using thrombopoietin
WO1995021919A2 (en) 1994-02-14 1995-08-17 Kirin Brewery Company, Limited Protein having tpo activity
CN1229385C (zh) 1994-03-31 2005-11-30 安姆根有限公司 刺激巨核细胞生长和分化的组合物及方法
US5571686A (en) 1994-04-14 1996-11-05 Massachusetts Institute Of Technology Method of using megapoietin for prolonging the survival & viability of platlets
AU4163196A (en) 1994-11-30 1996-06-19 Zymogenetics Inc. Low molecular weight thrombopoietin
AU705064B2 (en) 1995-04-26 1999-05-13 Kyowa Hakko Kogyo Co. Ltd. Novel polypeptides
TR199701526T1 (xx) * 1995-06-07 1998-03-21 Glaxo Group Limited Bir trombopoietin resept�r�ne ba�lanan peptitler ve bile�ikler.
US5869451A (en) 1995-06-07 1999-02-09 Glaxo Group Limited Peptides and compounds that bind to a receptor
US6251864B1 (en) * 1995-06-07 2001-06-26 Glaxo Group Limited Peptides and compounds that bind to a receptor
US6060052A (en) * 1995-10-30 2000-05-09 Systemix, Inc. Methods for use of Mpl ligands with primitive human hematopoietic stem cells
US5932546A (en) * 1996-10-04 1999-08-03 Glaxo Wellcome Inc. Peptides and compounds that bind to the thrombopoietin receptor
ATE350044T1 (de) 1999-09-24 2007-01-15 Smithkline Beecham Corp Thrombopoietinmimetika
AU2002307062A1 (en) 2001-04-02 2002-10-15 Purdue Pharma L.P. Thrombopoietin (tpo) synthebody for stimulation of platelet production
KR20050093759A (ko) 2002-09-18 2005-09-23 오르토-맥네일 파마슈티칼, 인코퍼레이티드 혈소판 및 조혈 줄기세포의 생산을 증가시키는 방법

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005023834A2 (en) * 2003-08-28 2005-03-17 Ortho-Mcneil Pharmaceutical, Inc. Peptides and compounds that bind to thrombopoietin receptors

Also Published As

Publication number Publication date
DK1957517T3 (da) 2013-04-08
CN101287749A (zh) 2008-10-15
NZ565497A (en) 2011-10-28
EA200800535A1 (ru) 2008-08-29
WO2007021572A3 (en) 2007-06-07
NI200800040A (es) 2010-11-25
NO344405B1 (no) 2019-12-02
PT1957517E (pt) 2013-05-28
ES2419005T3 (es) 2013-08-19
WO2007021572A2 (en) 2007-02-22
ECSP088169A (es) 2008-03-26
ZA200802184B (en) 2009-08-26
CY1114032T1 (el) 2016-07-27
CR9798A (es) 2008-09-09
IL189361A0 (en) 2008-06-05
AR055114A1 (es) 2007-08-08
JP2009504650A (ja) 2009-02-05
SI1957517T1 (sl) 2013-07-31
BRPI0614647A2 (pt) 2011-04-12
HRP20130518T1 (hr) 2013-07-31
NO20081298L (no) 2008-04-23
JO2859B1 (en) 2015-03-15
GT200600361A (es) 2007-03-14
EP1957517B1 (en) 2013-03-20
US20060040866A1 (en) 2006-02-23
SV2008002648A (es) 2008-11-28
TWI400081B (zh) 2013-07-01
TW200744626A (en) 2007-12-16
PL1957517T3 (pl) 2013-08-30
CA2618958A1 (en) 2007-02-22
PE20070416A1 (es) 2007-06-13
UY29736A1 (es) 2006-12-29
AU2006280230A1 (en) 2007-02-22
EP1957517A2 (en) 2008-08-20
HK1123811A1 (en) 2009-06-26
KR20080048026A (ko) 2008-05-30
MY152177A (en) 2014-08-15
UA96418C2 (ru) 2011-11-10
RS52802B (sr) 2013-10-31
US7723295B2 (en) 2010-05-25
IL189361A (en) 2015-11-30

Similar Documents

Publication Publication Date Title
US6251864B1 (en) Peptides and compounds that bind to a receptor
US5869451A (en) Peptides and compounds that bind to a receptor
US7576056B2 (en) Peptides and compounds that bind to a receptor
NO344405B1 (no) Peptidforbindelse som binder til TPO reseptor for terapeutisk behandling av blodplateforstyrrelse eller trombocytopeni hos mennesker
HK1123811B (en) Use of peptides that bind to tpo receptor
HK1163698B (en) Peptides and compounds that bind to a receptor
HK1163698A (en) Peptides and compounds that bind to a receptor
HK1096873B (en) Peptides and compounds that bind to thrombopoietin receptors

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired